Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lachmann

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Reviews on Recent Clinical Trials|May 1, 2015
Editorial: the urgent need to reform the present system of medicines' regulationPeter J Lachmann
Immunobiology|March 17, 2016
EditorialB Paul Morgan, Peter J Lachmann
Journal of Immunological Methods|April 7, 2018
A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3bPeter J Lachmann, Elizabeth Lay, David J Seilly
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2017
Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serumPeter J Lachmann, Elizabeth Lay, David J Seilly
Nature|October 5, 2013
Health care: Better drug access for terminal patientsDavid A Brindley, Richard W Barker, Peter J Lachmann
Immunology|April 2, 2004
The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensinsBarbara A Fernie-King, David J Seilly, Peter J Lachmann
Infection and Immunity|August 17, 2002
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozymeBarbara A Fernie-King, David J Seilly, Alexandra Davies, et al.
The Journal of Biological Chemistry|March 17, 2005
Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the moleculeMichael J Binks, Barbara A Fernie-King, David J Seilly, et al.
Microbes and Infection|February 17, 2007
Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activitiesBarbara A Fernie-King, David J Seilly, Michael J Binks, et al.
Gene Therapy|March 22, 2021
Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cellsAnna K Dreismann, Michelle E McClements, Alun R Barnard, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Reviews on Recent Clinical Trials|May 1, 2015
Editorial: the urgent need to reform the present system of medicines' regulationPeter J Lachmann
Immunobiology|March 17, 2016
EditorialB Paul Morgan, Peter J Lachmann
Journal of Immunological Methods|April 7, 2018
A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3bPeter J Lachmann, Elizabeth Lay, David J Seilly
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2017
Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serumPeter J Lachmann, Elizabeth Lay, David J Seilly
Nature|October 5, 2013
Health care: Better drug access for terminal patientsDavid A Brindley, Richard W Barker, Peter J Lachmann
Immunology|April 2, 2004
The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensinsBarbara A Fernie-King, David J Seilly, Peter J Lachmann
Infection and Immunity|August 17, 2002
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozymeBarbara A Fernie-King, David J Seilly, Alexandra Davies, et al.
The Journal of Biological Chemistry|March 17, 2005
Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the moleculeMichael J Binks, Barbara A Fernie-King, David J Seilly, et al.
Microbes and Infection|February 17, 2007
Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activitiesBarbara A Fernie-King, David J Seilly, Michael J Binks, et al.
Gene Therapy|March 22, 2021
Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cellsAnna K Dreismann, Michelle E McClements, Alun R Barnard, et al.
Pageof 3